PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
PSTV on Nasdaq
Shares outstanding
99,337,748
Price per share
$0.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,214,831
Total reported value
$3,565,788
% of total 13F portfolios
0.01%
Share change
+4,836,723
Value change
+$3,367,943
Number of holders
23
Price from insider filings
$0.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
S.H.N. Financial Investments Ltd. 1.5% -85% $525,000 +$101,586 1,500,000 +24% S.H.N. Financial Investments Ltd. 14 Aug 2025
HIRSCHMAN ORIN 3.9% -56% $410,778 +$231,288 1,283,681 +129% Orin Hirschman 30 Jun 2025

As of 30 Sep 2025, 23 institutional investors reported holding 5,214,831 shares of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV). This represents 5.2% of the company’s total 99,337,748 outstanding shares.

Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 25,910 $13,267 +$8 $0.40 2
2025 Q3 5,214,831 $3,565,788 +$3,367,943 $0.68 23
2025 Q2 378,108 $131,527 -$145,825 $0.35 17
2025 Q1 389,161 $368,744 -$387,710 $0.95 17
2024 Q4 678,173 $779,897 +$3,467 $1.15 10
2024 Q3 671,583 $980,510 -$14,830 $1.46 9
2024 Q2 681,593 $1,001,940 +$848,081 $1.47 11
2024 Q1 100,972 $181,848 -$69,240 $1.80 10
2023 Q4 139,925 $247,432 +$105,329 $1.75 12
2023 Q3 88,017 $117,891 -$18,399 $1.34 12
2023 Q2 101,711 $205,455 +$205,455 $2.02 7